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Aim To provide insights into the capacity to conduct 
health technology assessment (HTA) in Central, Eastern, 
and South-Eastern Europe (CESEE), taking account of tech-
nical, financial, networking, and human resources.
Methods An e-mail survey of 257 CESEE key informants 
involved in HTA was undertaken between March and April 
2014. Contact e-mail addresses were identified from the 
internet. The survey questionnaire consisted of 3 sections: 
i) characteristics of the organization performing HTA, (ii) 
networking in HTA, and (iii) resources allocated for HTA.
Results The survey was completed by 41 respondents 
representing a wide range of institutions from CESEE 
countries (response rate of 19.8%). Less than a quarter of 
respondents reported that their institutions had HTA-spe-
cific budgets, whereas the majority indicated that their in-
stitutions participated in HTA networks either at domestic 
or international levels. Although almost half of respon-
dents indicated that their institutions offered HTA training, 
a shortage in skills training was suggested as the main bar-
rier to HTA.
Conclusion This is the first survey to thoroughly assess the 
state of HTA capacity in the CESEE region. To strengthen 
HTA capacity, CESEE countries should increase financial, 
technical, and training resources. To strengthen collabo-
ration, the European Union and other international bod-
ies should assist existing HTA networks in fulfilling their 
regional activities through leadership, advocacy to local 
policymakers, funding, and technical assistance.
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Health technology assessment (HTA) is a multidisciplinary 
process that uses multiple approaches and techniques to 
provide comprehensive, objective information for health 
policymakers to make decisions on public access to and 
funding for products, services, and programs. Effective de-
cision-making should include multiple criteria (eg, medi-
cal, economic, ethical, social, legal, cultural), thus requiring 
multi-disciplinary teams of experts working together to 
produce assessments (1).
HTA methods and processes are increasingly used all around 
the world (2). In countries with mature systems in place (eg, 
Western Europe, North America), HTA products are integrat-
ed into policy, governance, reimbursement, and/or regula-
tion. By contrast, countries with greater budget and human 
resource limitations lack capacity to fulfil their HTA needs. 
These constraints lead policymakers and payers to con-
sider HTA products produced in other settings as an aid to 
decision-making at domestic level. However, there are criti-
cal factors that hamper the transferability of HTA products 
across jurisdictions, including unit costs, resource utilization, 
and unmet medical needs. In addition, decision-makers do 
not generally have the necessary skills to interpret and use 
HTA products, often resulting in decisions made intuitively or 
focused exclusively on budget impact considerations (3-6).
Although a number of publications have looked into the ca-
pacity to undertake HTA in Western European settings, no 
paper has thoroughly explored this issue in Central, Eastern, 
and South Eastern European (CESEE) countries as yet (4,7,8). 
Taking into consideration the problems faced by low- and 
middle-income countries, the European Commission’s Sev-
enth Framework Programme (FP7) ADVANCE_HTA project 
has among its aims to improve the implementation and ca-
pacity building of HTA in emerging settings (9). Hence, one 
of its sub-projects involves the mapping of current capacities 
to perform HTA in emerging settings of CESEE, not only in-
cluding decision-making bodies but also other institutions.
This article reports the findings from an international cross-
sectional survey of organizations involved with HTA pro-
cesses or decision-making. Specifically, the survey aims to 
provide insights into the capacity to conduct HTA of the 
CESEE countries, taking account of technical, financial, net-
working, and human resources.
MAtERiALs And MEthOds
A cross-sectional survey was performed in March-April 
2014 targeting people who worked at CESEE institutions 
potentially related with decision-making bodies or HTA 
processes, such as ministries of health, hospitals, universi-
ties, and public health agencies. E-mail addresses of poten-
tial survey respondents were identified by searching the 
databases of the following online resources: World Health 
Organization Regional Office for Europe (10), International 
Society for Pharmacoeconomics and Outcomes Research 
(ISPOR) Regional Chapters (11), Forum for Public Health in 
South Eastern Europe (12), Association of Schools of Pub-
lic Health in the European Region (ASPHER) (13), Europe-
an Health Technology Assessment Network (14), Europe-
an University Association (15), and the author information 
section of PubMed search.
A survey questionnaire was devised by following an iterative 
process. A draft was developed based on previous HTA ca-
pacity surveys undertaken by RedETSA (16) (HTA Network of 
the Americas) and EUnetHTA (European Network for Health 
Technology Assessment) in 2008 (17). The questionnaire was 
pilot tested among regional HTA experts and revised sever-
al times following the feedback received. The questionnaire 
consisted of three sections: (i) characteristics of the organiza-
tion performing HTA, (ii) networking in HTA, and (iii) resourc-
es allocated for HTA, with 23 questions. The time needed to 
fulfill the questionnaire was about 5-10 minutes.
All potential respondents were contacted via e-mail with a 
cover letter including a brief explanation of the survey, and 
assured of confidentiality. No ethical approval was needed, 
according to the project technical proposal, due to that we 
were not dealing with patient information data. To maxi-
mize response rates four reminders were sent.
REsuLts
A total of 257 subjects were identified and approached with 
a survey. A total of 41 responses were received, generating 
a response rate of 19.8%. A great heterogeneity in respon-
dent characteristics (eg, institution type, responsibility, HTA 
experience) was observed. Most replies were collected from 
Lithuania (5, 12.2% of all questionnaires received), followed 
by Romania and Slovenia with 4 replies each (9.76%), and 
Bulgaria, Greece, and Hungary with 3 replies each (7.32%). 
Montenegro, Kosovo, and Bosnia and Herzegovina offered 
no responses. Two respondents (both from Cyprus) rejected 
to answer the questionnaire because they felt unqualified. 
Thus, 39 replies were usable, with 29 respondents (74.4%) 
reporting that their organizations were capable to per-
form HTA and 2 of them (5.1%) being unaware of their 
institutions’ HTA activities.
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A total of 8 respondents (20.5%) indicated that their institu-
tions had HTA-specific budgets. The main lines of work re-
ported were heath policy (19, 65.5%) and HTA (18, 62.1%), 
followed by health care organization and management 
(15, 51.7%) and research (14, 48.3%). The main HTA product 
types produced were systematic reviews, economic eval-
uations, and technical reports/working documents (15, 
51.7% each). Concerning the scope of collaboration with 
other institutions, the majority of respondents reported 
having partnerships with domestic (government agency, 
79.3%; academia/university, 62.1%; professional associa-
tion, 58.6%) and international institutions (government 
agency, 58.6%; academia/university, 44.8%) (Supplemen-
tary Table 1).
When asked about bibliographic databases being used at 
institutional level, respondents cited MEDLINE/PubMed 
(96.6%), The Cochrane Library (79.3%), and Embase (65.5%) 
as the most common. Almost half of respondents (12, 
41.4%) indicated that their institutions offered HTA training 
to external participants, while well over half of respondents 
(19, 65.5%) reported having strategies for dissemination of 
HTA products. Requests to perform HTA were generally re-
ceived from governments (18, 62.1%) and private compa-
nies (9, 31%).
Finally, the most important limitation faced by institutions 
involved in HTA was funding limitation (n = 24), followed 
by lack of skills training (n = 21). Lack of access to network 
was mentioned by 11 respondents (4 respondents stated 
domestic network and 7 international network) and the 
lack of institutional support was stated by 5 respondents 
(Supplementary Table 1). With respect to barriers to con-
ducting HTA encountered by institutions not engaged in 
the practice, the most cited limitations were of political na-
ture (Table 1).
disCussiOn
This survey represents the first systematic attempt to map-
ping HTA capacity in the CESEE region. The ultimate goal 
of this study is to inform the development of a toolbox for 
emerging countries containing best practices and recom-
mendations on HTA and decision-making. The results of 
the present study suggest that there are several important 
areas that require attention so as to strengthen the capac-
ity of CESEE countries to undertake HTA.
First, although almost all survey respondents reported us-
ing MEDLINE/PubMed, the use of complementary data-
bases appears to be less common. This finding is worth 
mentioning because using just one bibliographic data-
base is considered inadequate. For instance, the overlap 
in journals covered by MEDLINE/PubMed and Embase is 
estimated to be just 34% (18). As a result, we recommend 
the involvement of librarians in HTA since it has shown to 
strengthen the capacity to produce HTAs (19).
Second, consistent with findings by the EunetHTA project 
on mature HTA systems, the main limitations to undertak-
ing HTA were lack of funding and training opportunities. 
The remarkable position occupied by the shortage of train-
ing initiatives has important implications, because the sur-
veyed institutions mostly engage in high impact activities 
such as health policy and HTA. Deficiencies in knowledge 
and skills in HTA producers may lead policymakers to disre-
gard the findings of HTA products, which ultimately would 
have a negative impact on health care quality (20,21). As 
the Cox report (22) suggests, by maximizing the potential 
of HTA, decision-makers will be better able to implement 
decisions that capture the benefits of new technologies, 
overcome uncertainties, and recognize the value of inno-
vation. Furthermore, well-conducted HTA require multidis-
ciplinary teams and adaptive human resources. This high-
lights the need for training programs to ensure that trained 
personnel, representing different disciplines but having a 
common language, can cooperate in performing HTAs (8). 
For these reasons, we recommend to increase funds for 
HTA, with emphasis on capacity building.
Lastly, as revealed by the survey results, HTA is no longer 
conducted in isolation. An increased and closer collabora-
tion at both national and international levels could help 
overcome the difficulties reported in the survey. Coopera-
tion among HTA organizations appears to be extremely rel-
evant for countries without institutionalized HTA, because 
it offers the opportunity to learn from others’ experiences 
tABLE 1. types of limitations faced by institutions not perform-
ing health technology assessment*
Limitation type Yes, n (%)
Lack of funding 2 (28.6)
Lack of time 0 (0)
Lack of human resources 1 (14.3)
Lack of access to network 1 (14.3)
Lack of institutional support 1 (14.3)
No interest 0 (0)
Others† 5 (71.5)
*Multiple choice answer.
†Lack of political support, no invitation from authorities and solely in 
health technology assessment agency.
69Olry de Labry Lima: Mapping capacity to conduct health technology assessment in Central, Eastern and South-Eastern Europe
www.cmj.hr
and benefit from HTA studies that have already been com-
pleted elsewhere. However, caution should be exercised, 
as the transferability of HTA evidence across settings is not 
always straightforward. Although both European Union 
(EU) countries and non-EU countries have a high level of 
collaboration in the field of HTA, more often than not, only 
a small proportion of an HTA institution’s activities are em-
bedded in international projects. Hence, the EU should 
promote and support transnational collaborations in HTA, 
because it can help reduce duplication, thereby enabling 
resources to be used more efficiently and assuring the 
quality and timeliness of HTA products.
It is plausible that a number of limitations may have influ-
enced the obtained results. The first is the relatively low 
response rate; survey participation is a particularly acute 
issue for web surveys, which tend to suffer from lower re-
sponse rates (10%-25%) than other survey modes (23). We 
found that this may be due to language barriers or con-
tacted individuals considering themselves unqualified to 
respond. Although attempts were made to increase the 
number of responses by sending reminders, this strategy 
did not render significant improvements. Nonetheless, 
the survey response rate echoes those obtained in similar 
studies related to HTA (8,24-27). The second is the repre-
sentativeness of the responses, since it is possible that re-
spondents answered on an individual rather than official 
basis (ie, not gathering a response from their institutions). 
These limitations underline the difficulty of collecting data 
on HTA from emerging settings, such as those within the 
CESEE region. Lastly, this low response rate could reflect 
the poor situation with HTA in these countries.
The findings of this international survey provide insights 
into the level of capacity in HTA of organizations from the 
CESEE region. Of particular note, the findings suggest a 
need for increased technical, financial, and training sup-
port, which could be fulfilled by reinforcing existing HTA 
networks and with additional support from international 
bodies, such as the EU.
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